GGrantIndex
← Search

PHASE I, SBIR CONTRACT, N43TR-14-001, ?MUTIPLEXED BIOMARKER ASSAY FOR CLASSIFICATION OF PATIENTS?.

$223,419N43FY2014DANIH

Celdara Medical, Llc, Lebanon NH

Investigators

Abstract

Aim I: Integrate autoantibodv profiles with gene expression . Autoantibodies in SSc have been associated with disease subtype (diffuse vs. limited) and internal organ involvement. Dr. Whitfield's prior gene expression studies have not found a significant correlation between gene expression and autoantibody profiles, although all of these studies were limited by incomplete data regarding the autoantibody profiles (only ANA , Scl70 and Anti-centromere were measured, and only in a subset of patients). The lack of correlation between autoantibody profiles and gene expression suggests that the two measures will provide complementary information regarding disease pathology.

View original record on NIH RePORTER →
PHASE I, SBIR CONTRACT, N43TR-14-001, ?MUTIPLEXED BIOMARKER ASSAY FOR CLASSIFICATION OF PATIENTS?. · GrantIndex